366 related articles for article (PubMed ID: 33741468)
1. Deciphering the epigenetic network in cancer radioresistance.
Cabrera-Licona A; Pérez-Añorve IX; Flores-Fortis M; Moral-Hernández OD; González-de la Rosa CH; Suárez-Sánchez R; Chávez-Saldaña M; Aréchaga-Ocampo E
Radiother Oncol; 2021 Jun; 159():48-59. PubMed ID: 33741468
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics as a determinant of radiation response in cancer.
Arechaga-Ocampo E
Int Rev Cell Mol Biol; 2024; 383():145-190. PubMed ID: 38359968
[TBL] [Abstract][Full Text] [Related]
3. Impact of DNA and RNA Methylation on Radiobiology and Cancer Progression.
Chi HC; Tsai CY; Tsai MM; Lin KH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439529
[TBL] [Abstract][Full Text] [Related]
4. Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications.
Silverman BR; Shi J
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999365
[TBL] [Abstract][Full Text] [Related]
5. Romance of the three kingdoms in hypoxia: HIFs, epigenetic regulators, and chromatin reprogramming.
Chen Y; Liu M; Niu Y; Wang Y
Cancer Lett; 2020 Dec; 495():211-223. PubMed ID: 32931886
[TBL] [Abstract][Full Text] [Related]
6. Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II α.
Kim JS; Kim SY; Lee M; Kim SH; Kim SM; Kim EJ
Cancer Biol Ther; 2015; 16(4):558-66. PubMed ID: 25719218
[TBL] [Abstract][Full Text] [Related]
7. The Advances in Epigenetics for Cancer Radiotherapy.
Wang Y; Han Y; Jin Y; He Q; Wang Z
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628460
[TBL] [Abstract][Full Text] [Related]
8. The promise of epigenetic therapy: reprogramming the cancer epigenome.
Kelly AD; Issa JJ
Curr Opin Genet Dev; 2017 Feb; 42():68-77. PubMed ID: 28412585
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
Castilho RM; Squarize CH; Almeida LO
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704968
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
[TBL] [Abstract][Full Text] [Related]
13. The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance.
Macedo-Silva C; Miranda-Gonçalves V; Henrique R; Jerónimo C; Bravo I
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31739546
[TBL] [Abstract][Full Text] [Related]
14. Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential.
Xu X; Peng Q; Jiang X; Tan S; Yang Y; Yang W; Han Y; Chen Y; Oyang L; Lin J; Xia L; Peng M; Wu N; Tang Y; Li J; Liao Q; Zhou Y
Exp Mol Med; 2023 Jul; 55(7):1357-1370. PubMed ID: 37394582
[TBL] [Abstract][Full Text] [Related]
15. Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents.
Oronsky B; Scicinski J; Kim MM; Cabrales P; Salacz ME; Carter CA; Oronsky N; Lybeck H; Lybeck M; Larson C; Reid TR; Oronsky A
Biomolecules; 2016 Jul; 6(3):. PubMed ID: 27384589
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
Fanale D; Castiglia M; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges.
Vaiopoulos AG; Athanasoula KCh; Papavassiliou AG
Biochim Biophys Acta; 2014 Jul; 1842(7):971-80. PubMed ID: 24561654
[TBL] [Abstract][Full Text] [Related]
18. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.
Lin HY; Hung SK; Lee MS; Chiou WY; Huang TT; Tseng CE; Shih LY; Lin RI; Lin JM; Lai YH; Chang CB; Hsu FC; Chen LC; Tsai SJ; Su YC; Li SC; Lai HC; Hsu WL; Liu DW; Tai CK; Wu SF; Chan MW
Oncotarget; 2015 Jan; 6(2):915-34. PubMed ID: 25460508
[TBL] [Abstract][Full Text] [Related]
19. Targeting Chromatin Remodeling for Cancer Therapy.
Kaur J; Daoud A; Eblen ST
Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
[TBL] [Abstract][Full Text] [Related]
20. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
